Lluís Montoliu

CSIC scientific researcher at the Department of Molecular and Cellular Biology of the Spanish National Centre for Biotechnology (CNB-CSIC) and the Centre for Biomedical Network Research on Rare Diseases (CIBERER-ISCIII) in Madrid (Spain). His team is pioneering the use of CRISPR in Spain to investigate rare human diseases such as albinism using animal models. In 2006, he founded the International Society for Transgenic Technologies (ISTT), which he chaired until 2014. He currently directs the European Society for Pigment Cell Research (ESPCR) and is a member of the CSIC ethics committee and the European Research Council (ERC) ethics panel.


The Nobel Prize for Chemistry has awarded Emmanuelle Charpentier and Jennifer A. Doudna for the development of CRISPR-Cas9 genetic editing tools. Lluís Montoliu analyses the journey to this award.
Las herramientas de edición genética CRISPR

Communication is essential in all areas of society, but communication in science is inescapable. Communicating means sharing, showing, teaching, and transferring knowledge both to colleagues and to society in general.


The communication of biotechnology has played a key role in recent years. The great advances made and the speed with which new genetic editing techniques are implemented raise enormous expectations but also concerns.